Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

18,214 total articles

Greenland Energy Company Rings Nasdaq Opening Bell as CEO Highlights Transformational Arctic Exploration Opportunity

Greenland Energy Company Rings Nasdaq Opening Bell as CEO Highlights Transformational Arctic Exploration Opportunity

Greenland Energy Company (NASDAQ: GLND) marked its public listing by ringing the Nasdaq Opening Bell. The company aims to advance its hydrocarbon exploration in Greenland’s Jameson Land Basin with plans to drill two wells in 2026, targeting a large, underexplored area with significant potential based on legacy seismic data. Management views this as…

TRULY HARD SELTZER BELIEVES U.S. SOCCER WILL WIN THIS SUMMER — AND THEY’RE RENAMING A REAL AMERICAN TOWN TO PROVE IT

TRULY HARD SELTZER BELIEVES U.S. SOCCER WILL WIN THIS SUMMER — AND THEY’RE RENAMING A REAL AMERICAN TOWN TO PROVE IT

The Boston Beer Company, through its Truly Hard Seltzer brand, is launching an expansive nationwide marketing campaign aligned with the 2026 U.S. men's soccer tournament. Highlighting fan passion, the campaign includes renaming an American town to Believe, USA, limited-edition soccer-themed cans, and a new Star Squad Pack variety pack. The initiati…

MAIA Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy

MAIA Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy

MAIA Biotechnology has successfully raised $33 million in a public offering to fully finance its ongoing pivotal Phase 3 trial of ateganosine, a novel dual-mechanism telomere-targeting immunotherapy for third-line non-small cell lung cancer (NSCLC). The FDA granted Fast Track designation to ateganosine, which aims to improve outcomes in NSCLC patie…

Kratos Receives $446.8 Million Space Systems Command Contract for Resilient Missile Warning and Missile Tracking Ground Management & Integration (GMI)

Kratos Receives $446.8 Million Space Systems Command Contract for Resilient Missile Warning and Missile Tracking Ground Management & Integration (GMI)

Kratos Defense & Security Solutions, Inc. has received a $446.8 million contract from the U.S. Space Force's Space Systems Command to serve as the prime contractor for the Ground Management and Integration of the Resilient Missile Warning and Tracking program. The contract involves developing an integrated ground system to operate missile warning s…

Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026

Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026

Autonomix Medical, Inc., a NASDAQ-listed medical device company, announced its abstract on long-term pain mitigation in pancreatic cancer using transvascular RF energy-based ablation has been selected as a Featured Abstract for podium presentation at the Society of Interventional Radiology Annual Scientific Meeting in 2026. This recognition highlig…

Lakeland Fire + Safety Awarded Emergency Follow-On Orders from National Fire Department of Colombia for Head-to-Toe Fire Gear

Lakeland Fire + Safety Awarded Emergency Follow-On Orders from National Fire Department of Colombia for Head-to-Toe Fire Gear

Lakeland Fire + Safety, a NASDAQ-listed protective clothing manufacturer, announced significant emergency follow-on orders from the National Fire Department of Colombia for turnout gear, gloves, and hoods. These orders follow successful initial deployments amid increasing wildfire risks in Colombia driven by climate change and environmental degrada…

Ruanyun Edai Technology Secures $1.73 Million Strategic Financing to Accelerate Global Expansion and Transition of Its New Identity Formind Group

Ruanyun Edai Technology Secures $1.73 Million Strategic Financing to Accelerate Global Expansion and Transition of Its New Identity Formind Group

Ruanyun Edai Technology Inc., an AI-driven education technology company listed on NASDAQ, announced the closing of $1.73 million in strategic financing led by AC Sunshine Securities to accelerate its global growth, particularly in the Middle East and North Africa (MENA) region. The funding supports expansion of their Saudi Arabia Regional Headquart…

Ondo Global Markets Tokenizes Enlivex’s Ordinary Shares

Ondo Global Markets Tokenizes Enlivex’s Ordinary Shares

Enlivex Ltd., a clinical-stage longevity therapeutics company listed on Nasdaq, has partnered with Ondo Finance to launch ENLVon — a tokenized digital representation of its ordinary shares. This strategic move enables non-U.S. retail and institutional investors to access Enlivex's stock through digital wallets without traditional brokerage accounts…

CISO Global Files No-Action Request with SEC Seeking Investor-Consent Framework for Securities Lending

CISO Global Files No-Action Request with SEC Seeking Investor-Consent Framework for Securities Lending

CISO Global, Inc. has filed a no-action request with the SEC to establish an Investor-Consent Share Loan Program allowing shareholders to opt in before their shares are made available for securities lending. The proposal aims to increase transparency and give shareholders control over lending activities that facilitate short selling, aligning with …

GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions

GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions

GRI Bio, Inc., a US-based clinical-stage biotech company, announced it received a Notice of Allowance from the UAE Patent Office for novel type 2 diverse NKT cell agonists designed to treat inflammatory conditions. This patent strengthens the company's global intellectual property portfolio and supports its immunomodulatory platform focused on infl…

Jet.AI Announces $5 Million SPV Economic Interest in xAI (SpaceX)

Jet.AI Announces $5 Million SPV Economic Interest in xAI (SpaceX)

Jet.AI Inc. announced a $5 million investment via a Special Purpose Vehicle (SPV) acquiring economic interest in SpaceX and its subsidiaries, including xAI. The move aligns with Jet.AI's strategic pivot towards AI infrastructure and aims to capitalize on SpaceX's projected IPO, potentially the largest-ever, with a valuation of $1.75-$2 trillion. Th…

Kaltura Spotlighted In The 2026 WealthTech100 List for Pioneering AI-Powered Digital Engagement in Wealth and Financial Management

Kaltura Spotlighted In The 2026 WealthTech100 List for Pioneering AI-Powered Digital Engagement in Wealth and Financial Management

Kaltura, a Nasdaq-listed company, has been named to the 2026 WealthTech100 list for its pioneering AI-driven digital engagement solutions in wealth and financial management sectors. The recognition highlights Kaltura's advanced Agentic Avatar technology and comprehensive digital experience platform that enhances client-advisor interactions, operati…

Westwood Announces Monthly Income Distributions for Westwood Salient Enhanced Midstream Income ETF (MDST), Westwood Salient Enhanced Energy Income ETF (WEEI) and Westwood Enhanced Income Opportunity (YLDW)

Westwood Announces Monthly Income Distributions for Westwood Salient Enhanced Midstream Income ETF (MDST), Westwood Salient Enhanced Energy Income ETF (WEEI) and Westwood Enhanced Income Opportunity (YLDW)

Westwood Holdings Group reported monthly income distributions for three of its actively managed ETFs—MDST, WEEI, and YLDW—focused on energy infrastructure and income-generating assets. The ETFs combine dividend yields with options premium income from covered calls to provide attractive monthly distributions, appealing to investors seeking income an…

Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline

Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline

Curanex Pharmaceuticals highlighted five additional patient cases demonstrating encouraging improvements in functional status, appetite, mobility, and overall condition among critically ill patients suffering from advanced cancers and severe systemic diseases after taking its lead candidate. These observations suggest potential therapeutic benefits…

OR Royalties Announces Preliminary Q1 2026 GEO Deliveries and C$17.7 Million of Share Repurchases Under the Normal Course Issuer Bid

OR Royalties Announces Preliminary Q1 2026 GEO Deliveries and C$17.7 Million of Share Repurchases Under the Normal Course Issuer Bid

OR Royalties announced strong preliminary Q1 2026 results with record revenues of $102.8 million, a high cash margin of nearly 97%, and 22,740 attributable gold equivalent ounces delivered. The company repurchased C$17.7 million of shares under its normal course issuer bid and maintained a robust cash position of approximately $94.9 million. OR Roy…